New York, Jan 6, 2026, 0947 EST — Regular session
Key points:
- NuScale shares rose in early trading, extending Monday’s sharp gain on heavy volume.
- Nuclear-linked stocks broadly firmed after the U.S. unveiled $2.7 billion in uranium-enrichment orders.
- Investors are watching a U.S. House energy hearing on nuclear licensing on Jan. 7.
NuScale Power shares were up 4.7% at $19.67 in morning trade on Tuesday, after jumping 15.1% in the previous session as traders piled back into nuclear-related names.
The latest leg higher followed a U.S. push to shore up the nuclear fuel supply chain. The Energy Department said on Monday it awarded orders totaling $2.7 billion to three companies to expand domestic uranium enrichment over the next decade, including high-assay low-enriched uranium, or HALEU, a fuel needed for some advanced reactor designs. Energy Secretary Chris Wright said the awards showed the administration was committed to “restoring a secure domestic nuclear fuel supply chain.” Reuters
Why it matters now: fuel and licensing are two choke points for next-generation nuclear projects, and investors have been trading the group on policy headlines as much as company-specific progress. HALEU is uranium enriched between 5% and 20%, above the roughly 5% enrichment used in most of today’s reactors.
Other nuclear-linked stocks also gained on Tuesday. Oklo rose 5.7%, while Centrus Energy and uranium miner Cameco were up 4.7% and 1.1%, respectively.
NuScale closed on Monday at $18.78, after trading as high as $19.55, with volume of about 68.2 million shares, according to Yahoo Finance data.
In Tuesday’s session, NuScale touched $20.30 before easing back, keeping the round $20 level in focus after the stock opened at $19.55. Traders often treat such levels as near-term pivots, with momentum funds quick to cut positions if the breakout fails.
In Washington, the House Energy and Commerce Committee’s Subcommittee on Energy has scheduled a hearing for Wednesday, Jan. 7, on issues including licensing reform, nuclear supply chains and fuels, and the outlook for advanced reactor technology. Witnesses include Nuclear Energy Institute CEO Maria Korsnick and Idaho National Laboratory director John Wagner, according to a committee memo.
But the trade carries risks. NuScale has relied on capital markets and, in November, disclosed a new at-the-market program allowing it to sell up to $750 million of stock, a structure that can dilute existing shareholders if tapped during rallies.
NuScale is developing small modular reactors, smaller nuclear plants designed to be built with standardized parts and scaled in units. The U.S. Nuclear Regulatory Commission approved NuScale’s upgraded design in May 2025, a key step toward commercialization, after the company scrapped its first U.S. project in 2023 as costs rose.
Related articles: NYSE:SMR
